Jazz Pharmaceuticals plc
JAZZ
$229.63
$0.440.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -93.88% | -163.58% | -179.55% | -202.50% | 45.78% |
| Total Depreciation and Amortization | 7.76% | 5.48% | 5.32% | 3.75% | 2.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 235.66% | 294.90% | 365.40% | 479.66% | 13.38% |
| Change in Net Operating Assets | -281.73% | 124.50% | 106.53% | 17.24% | 192.98% |
| Cash from Operations | -14.39% | -2.87% | 19.51% | 22.63% | 50.07% |
| Capital Expenditure | -43.28% | -54.38% | -58.60% | -79.40% | -66.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.22% | -32.16% | -134.38% | 120.90% | 10.64% |
| Cash from Investing | -200.50% | -197.13% | -524.61% | -31.21% | 5.78% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 97.71% | -28.89% | -28.89% | -4,274.35% | -4,274.35% |
| Issuance of Common Stock | 308.54% | 422.67% | 57.24% | 20.97% | 23.04% |
| Repurchase of Common Stock | 38.86% | 45.75% | 56.64% | 10.52% | -18.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 81.20% | -4,357.23% | -1,238.36% | -76.54% | -121.80% |
| Foreign Exchange rate Adjustments | 158.85% | 491.64% | 76.36% | 521.72% | 293.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.22% | -212.63% | -201.10% | -325.86% | 51.91% |